Magnolia Neurosciences Corp — Form D/A
Magnolia Neurosciences Corp of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2021-11-23. The offering totals $18.4M, of which $18.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-11-23
- Form: D/A
- Accession: 0001749206-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $18.4M
- Amount sold: $18.4M
- Remaining: $16K
- Investors: 9
- Date of first sale: 2020-07-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-371555
Issuer
- Name: Magnolia Neurosciences Corp
- CIK: 0001749206
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 430 EAST 29TH STREET, NEW YORK, NY, 10016
- Phone: 646.828.5990
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Michael Baran | Director | New York, NY |
| Steve Gillis | Director | New York, NY |
| THONG LE | Director | Seattle, WA |
| Alice Ly | Director | New York, NY |
| Ian Howes | Executive Officer | Seattle, WA |
| THONG LE | Executive Officer | Seattle, WA |
| Kendall Mohler | Executive Officer | Seattle, WA |
| Asish Xavier | Director | South San Francisco, CA |
| Alice Johnston Ly | Director | New York, NY |
| M. Johnston Erwin | Director | New York, NY |
| Margarita Johnston Chavez | Director | New York, NY |
| David Schubert | Executive Officer | New York, NY |
| Michael Johnston Baran | Director | New York, NY |
| Barbara Johnston Dalton | Director | New York, NY |
| Joel Johnston Marcus | Director | Seattle, WA |
Other filings by this issuer (2)
More